Richard W. Pascoe - 18 May 2022 Form 4 Insider Report for KEMPHARM, INC (ZVRA)

Role
Executive Chairman, Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Richard W. Pascoe
Issuer symbol
ZVRA
Transactions as of
18 May 2022
Transactions value $
$24,608
Form type
4
Filing time
18 May 2022, 17:25:01 UTC
Previous filing
03 Feb 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Purchase $1.47K +300 +9.13% $4.90 3.59K 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $490 +100 +2.79% $4.90 3.69K 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $1.96K +400 +10.85% $4.91 4.09K 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $1.96K +400 +9.79% $4.91 4.49K 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $8.69K +1.77K +39.4% $4.92 6.25K 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $8.38K +1.7K +27.19% $4.93 7.95K 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $1.65K +333 +4.19% $4.94 8.29K 18 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.